Skip to main content
VCbacked
Log inGet Started

Faraday Pharmaceuticals

Seattle, United States

Faraday Pharmaceuticals is an early-stage therapeutics company focused on developing novel therapies to treat ischemia-reperfusion injury.

$52.8M raised
Nov 2022
Series C
BiotechnologyPharmaceuticalTherapeutics

Top Investors

ARCH Venture PartnersPolaris PartnersOUP (Osage University Partners)Alexandria Real Estate EquitiesWashington Research Foundation

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Faraday Pharmaceuticals

How much funding has Faraday Pharmaceuticals raised?
Faraday Pharmaceuticals has raised $52.8M in total funding. The most recent round was Series C. The last funding was announced in November 2022.
Who are Faraday Pharmaceuticals's investors?
Faraday Pharmaceuticals's investors include ARCH Venture Partners, Polaris Partners, OUP (Osage University Partners), Alexandria Real Estate Equities, Washington Research Foundation.
Where is Faraday Pharmaceuticals headquartered?
Faraday Pharmaceuticals is headquartered in Seattle, United States.
What does Faraday Pharmaceuticals do?
Faraday Pharmaceuticals is an early-stage therapeutics company focused on developing novel therapies to treat ischemia-reperfusion injury.
What stage is Faraday Pharmaceuticals at?
Faraday Pharmaceuticals is at the Series C stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Faraday Pharmaceuticals — Funding & Investors." VCBacked, November 7, 2022, https://www.vcbacked.co/company/faraday-pharmaceuticals. Accessed July 3, 2026.
APA
VCBacked. (2022). Faraday Pharmaceuticals — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/faraday-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Faraday Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/faraday-pharmaceuticals |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Rapport Therapeutics
Boston$250.0M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K